Category: Laser/Light-based Devices
Inventor Dr. Rangaswamy Srinivasan recounts how leftover Thanksgiving turkey turned out to be the perfect testing ground for the excimer laser that laid the foundation for LASIK laser eye surgery.
If you are among the tens of millions of patients who have undergone laser vision-correction surgery, you may want to be extra thankful for your Thanksgiving turkey this year, as it played an important role in bringing LASIK technology out of the lab and into the clinic.
Florida medical device maker LENSAR touts the launch of a U.K. clinical trial evaluating its laser system in treatment of patients with presbyopia.
Orlando, Fla.-based LENSAR Inc. announced the launch of a new U.K. clinical trial, evaluating the company's laser-based lens softening system in treatment of patients with presbyopia.
The study begins with enrollment of the 1st 30 patients and will expand to more sites by the end of the year, LENSAR said.
Lumenis Ltd. won FDA 510(k) and Japanese MHLW clearance for its Array LaserLink pattern scanning device for multi-spot retinal laser treatment.
Lumenis Ltd. announced today regulatory wins in the U.S. and Japan for its Array LaserLink pattern scanning device for multi-spot laser photocoagulation for use during retinal surgery.
The Array LaserLink, which turns an "examination slit lamp" into a medical laser, expands on the Lumenis laser system to deliver "pattern scanning capabilities, aimed to provide greater predictability in retinal treatments and presumably less collateral damage to the retina," according to a press release.
Florida laser cataract surgery technology company LENSAR touts $87 million raised through private equity and debt financing.
Orlando, Fla.-based medical device company LENSAR Inc. touted $87 million in fundraising, mostly through a debt financing agreement, in support of its laser cataract surgery systems.
LENSAR raised $27 million in private equity financing and secured up to $60 million in debt financing. The company plans to use the funds to advance commercialization worldwide and to advance development of its cataract surgery platform.
OmniGuide Surgical says it raised a $15 million funding round for its BeamPath surgical laser, saying it plans to use the cash to boost its commercialization efforts.
OmniGuide Surgical said it raised a $15 million funding round for its BeamPath surgical layer.
The Cambridge, Mass.-based medical device company said it plans to use the round to expand BeamPath's footprint in the gynecological market and launch new ear, nose & throat products.
AngioDynamics is still looking for a judge to hand down sanctions against rival laser devices maker Biolitec, which AngioDynamics accuses of patent infringement and refusal to follow court orders.